Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21

BACKGROUND: Since March 2020, 440 million people worldwide have been diagnosed with COVID-19, but the true number of infections with SARS-CoV-2 is higher. SARS-CoV-2 antibody seroprevalence can add crucial epidemiological information about population infection dynamics. AIM: To provide a large popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Anda, Erik Eik, Braaten, Tonje, Borch, Kristin Benjaminsen, Nøst, Therese Haugdahl, Chen, Sairah L F, Lukic, Marko, Lund, Eiliv, Forland, Frode, Leon, David A, Winje, Brita Askeland, Kran, Anne-Marte Bakken, Kalager, Mette, Johansen, Fridtjof Lund, Sandanger, Torkjel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973017/
https://www.ncbi.nlm.nih.gov/pubmed/35362405
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.13.2100376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973017/
https://www.ncbi.nlm.nih.gov/pubmed/35362405
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.13.2100376

Ejemplares similares